Medical Xpress·3 min read·hard
Experimental drug may protect the heart in Duchenne muscular dystrophy
K
Kurt Loft
✦AI Summary
Researchers at the University of South Florida have identified that the experimental drug Setanaxib may protect cardiac function in patients with Duchenne muscular dystrophy. The study suggests that targeting the NOX4 enzyme could reduce heart enlargement and tissue scarring.
Why it matters
This discovery offers a potential new therapeutic pathway for managing the severe heart complications associated with a fatal genetic disease.
by Kurt Loft, University of South Florida
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
Scientific reporting based on peer-reviewed research findings.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in